{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:43:44Z","timestamp":1788468224588,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2014.12.002","type":"journal-article","created":{"date-parts":[[2015,4,18]],"date-time":"2015-04-18T01:31:08Z","timestamp":1429320668000},"page":"930-938","source":"Crossref","is-referenced-by-count":44,"title":["Efficacy and Safety of Cilostazol Therapy in Ischemic Stroke: A Meta-analysis"],"prefix":"10.1016","volume":"24","author":[{"given":"Liang","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnhart","family":"Margaret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7853-9223","authenticated-orcid":false,"given":"Hua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib1","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","article-title":"Prevalence, incidence, and\u00a0factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis","volume":"8","author":"Pendlebury","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib2","doi-asserted-by":"crossref","first-page":"e601S","DOI":"10.1378\/chest.11-2302","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Lansberg","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Furie","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib4","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1345\/aph.1C013","article-title":"Aspirin resistance","volume":"36","author":"Howard","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib5","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jama.280.22.1930","article-title":"Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials","volume":"280","author":"He","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib6","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1161\/01.STR.0000174189.81153.85","article-title":"Risk of hemorrhagic stroke with aspirin use: an update","volume":"36","author":"Gorelick","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib7","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1161\/STROKEAHA.107.497271","article-title":"Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review","volume":"39","author":"O'Donnell","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (caprie). Caprie steering committee","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib9","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (match): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0006-2952(99)00346-9","article-title":"Potent effects of novel\u00a0anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity","volume":"59","author":"Sudo","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib12","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2174\/1381612033453910","article-title":"Cilostazol as a unique antithrombotic agent","volume":"9","author":"Kambayashi","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jacc.2013.01.004","article-title":"Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF\/AHA guideline recommendations): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"Anderson","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/1074248413495971","article-title":"Comparison of on-treatment platelet reactivity between triple antiplatelet therapy with cilostazol and standard dual antiplatelet therapy in patients undergoing coronary interventions: a meta-analysis","volume":"18","author":"Panchal","year":"2013","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.smrv.2010.04.001","article-title":"A systematic review of insomnia and complementary medicine","volume":"15","author":"Sarris","year":"2011","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib17","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib18","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2011"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib19","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib22","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/STROKEAHA.110.609370","article-title":"Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis","volume":"42","author":"Kwon","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1474-4422(10)70198-8","article-title":"Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial","volume":"9","author":"Shinohara","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.02.009","article-title":"Cilostazol for the prevention of acute progressing stroke: a multicenter, randomized controlled trial","volume":"22","author":"Shimizu","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000327036","article-title":"Cilostazol in acute ischemic stroke treatment (CAIST Trial): a randomized double-blind non-inferiority trial","volume":"32","author":"Lee","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.STR.0000157667.06542.b7","article-title":"Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis","volume":"36","author":"Kwon","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2011.09.038","article-title":"Cilostazol combined with aspirin prevents early neurological deterioration in patients with acute ischemic stroke: a pilot study","volume":"313","author":"Nakamura","year":"2012","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s12264-009-6192-2","article-title":"Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke","volume":"25","author":"Guo","year":"2009","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1474-4422(08)70094-2","article-title":"Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study","volume":"7","author":"Huang","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/jscd.2000.7216","article-title":"Cilostazol stroke prevention study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction","volume":"9","author":"Gotoh","year":"2000","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000089723","article-title":"Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles","volume":"43","author":"Nakamura","year":"2006","journal-title":"J Vasc Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib32","doi-asserted-by":"crossref","first-page":"e39374","DOI":"10.1371\/journal.pone.0039374","article-title":"Cilostazol inhibits accumulation of triglyceride in aorta and platelet aggregation in cholesterol-fed rabbits","volume":"7","author":"Ito","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib33","first-page":"294","article-title":"Cilostazol strengthens the endothelial barrier of postcapillary venules from the rat mesentery in situ","volume":"29","author":"Sugiura","year":"2013","journal-title":"Phlebology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neulet.2009.01.039","article-title":"Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damage","volume":"452","author":"Nonaka","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","article-title":"Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Goldstein","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/003693300505000209","article-title":"Timing of aspirin and secondary preventative therapies in acute stroke: support for use of stroke units","volume":"50","author":"Reid","year":"2005","journal-title":"Scott Med J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/2013.jamaneurol.547","article-title":"Timing of recanalization after intravenous thrombolysis and functional outcomes after acute ischemic stroke","volume":"70","author":"Yeo","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib38","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1468-2982.2006.01218.x","article-title":"The headache-inducing effect of cilostazol in human volunteers","volume":"26","author":"Birk","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib39","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.clinthera.2013.09.004","article-title":"Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis","volume":"35","author":"Malloy","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib40","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.amjcard.2013.05.067","article-title":"Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke","volume":"112","author":"Dinicolantonio","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib41","first-page":"CD008076","article-title":"Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin","author":"Kamal","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.12.002_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/2047-783X-18-53","article-title":"Systematic study of cilostazol on secondary stroke prevention: a meta-analysis","volume":"18","author":"Qian","year":"2013","journal-title":"Eur J Med Res"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305714005977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305714005977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T15:13:10Z","timestamp":1566573190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305714005977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1052305714005977"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.12.002","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}